Loomis Sayles & CO L P Biocryst Pharmaceuticals Inc Transaction History

Loomis Sayles & CO L P

  • $70.3 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$7.89 - $17.88 $18.6 Million - $42.1 Million
-2,356,216 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$11.56 - $19.76 $10.6 Million - $18.2 Million
919,104 Added 63.95%
2,356,216 $38.3 Million
Q4 2021

Feb 14, 2022
BUY
$11.18 - $15.46 $16.1 Million - $22.2 Million
1,437,112 New
1,437,112 $19.9 Million

Others Institutions Holding BCRX

# of Institutions
258
Shares Held
182M
Call Options Held
839K
Put Options Held
816K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.15B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email